Related Experiment Video
Updated: Mar 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1
Wen-Jian Yao1, Yong-Lian Wang1, Jian-Guo Lu1
1Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, China.
Abstract:
MicroRNAs (miRNAs) act as key regulators of multiple cancers. MicroRNA-506 (miR-506) functions as a tumor suppressor in various types of cancers. However, its role in esophageal cancer remains unclear. In our study, we found that miR-506 was significantly down-regulated in esophageal cancer tissues and cell lines. In vitro assay, our results showed that ectopic over-expression of miR-506 inhibited esophageal cancer cells proliferation, meanwhile, cells proliferation was promoted by miR-506 inhibition. In exploring mechanisms underlying the inhibitive role, we found that miR-506 significantly decreased the expression and transcription activity of cAMP responsive element binding protein 1 (CREB1). CREB1, tumor oncogene, exhibited significantly promote effect on esophageal cancer cell proliferation. Taken together, our data identify a new role of miR-506 in esophageal cancer involving CREB1 suppression.
Insights
MicroRNA-506 (miR-506) suppresses esophageal cancer by down-regulating the oncogene CREB1. This study reveals miR-506 as a potential therapeutic target for esophageal cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are crucial regulators in cancer development.
- MicroRNA-506 (miR-506) is recognized as a tumor suppressor in several cancers.
- The specific function of miR-506 in esophageal cancer is not well-defined.
Purpose of the Study:
- To investigate the role and mechanism of miR-506 in esophageal cancer.
- To determine the expression levels of miR-506 in esophageal cancer tissues and cell lines.
- To identify potential targets of miR-506 in esophageal cancer.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess miR-506 expression.
- In vitro assays to evaluate the effect of miR-506 on esophageal cancer cell proliferation.
- Western blot and luciferase reporter assays to analyze CREB1 expression and activity.
Main Results:
- miR-506 was significantly downregulated in esophageal cancer tissues and cell lines.
- Overexpression of miR-506 inhibited esophageal cancer cell proliferation, while inhibition of miR-506 promoted it.
- miR-506 directly targeted and suppressed the expression and transcriptional activity of CREB1.
- CREB1 was identified as a tumor oncogene promoting esophageal cancer cell proliferation.
Conclusions:
- miR-506 acts as a tumor suppressor in esophageal cancer.
- The tumor-suppressive function of miR-506 is mediated through the inhibition of CREB1.
- miR-506 represents a potential therapeutic biomarker and target for esophageal cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Mitogens and the Cell Cycle
Induced Pluripotent Stem Cells
Somatic...

